162 related articles for article (PubMed ID: 35185351)
1. The Role of AMACR, CD10, TMPRSS2-ERG, and p27 Protein Expression Among Different Gleason Grades of Prostatic Adenocarcinoma on Needle Biopsy.
Gülhan Ö; Mahi B
Clin Med Insights Oncol; 2020; 14():1179554920947322. PubMed ID: 35185351
[TBL] [Abstract][Full Text] [Related]
2. Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative α-methylacyl-CoA racemase vs. ERG expression.
Warrick JI; Humphrey PA
Am J Surg Pathol; 2013 Nov; 37(11):1709-14. PubMed ID: 23797726
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of immunohistochemical markers alpha methyl acyl coA racemase (AMACR) and Ets related gene (ERG) in prostate cancer.
Stephen N; Badhe BA
Int J Clin Exp Pathol; 2022; 15(9):364-372. PubMed ID: 36237639
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of Ets-related gene-transcriptional factor in adenocarcinoma prostate and its correlation with Gleason score.
Mannan R; Bhasin TS; Manjari M; Singh G; Bhatia PK; Sharma S
Indian J Pathol Microbiol; 2016; 59(4):489-495. PubMed ID: 27721279
[TBL] [Abstract][Full Text] [Related]
5. Utility of ERG versus AMACR expression in diagnosis of minimal adenocarcinoma of the prostate in needle biopsy tissue.
Andrews C; Humphrey PA
Am J Surg Pathol; 2014 Jul; 38(7):1007-12. PubMed ID: 24705308
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study.
Sayed RMS; El Shorbagy G; Shibel PEE
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2861-2868. PubMed ID: 37642075
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
Herawi M; Epstein JI
Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
[TBL] [Abstract][Full Text] [Related]
8. High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer.
Box A; Alshalalfa M; Hegazy SA; Donnelly B; Bismar TA
Tumour Biol; 2016 Sep; 37(9):12287-12299. PubMed ID: 27271990
[TBL] [Abstract][Full Text] [Related]
9. Age-associated changes in alpha-methyl CoA racemase (AMACR) expression in nonneoplastic prostatic tissues.
Gologan A; Bastacky S; McHale T; Yu J; Cai C; Monzon-Bordonaba F; Dhir R
Am J Surg Pathol; 2005 Nov; 29(11):1435-41. PubMed ID: 16224209
[TBL] [Abstract][Full Text] [Related]
10. Expression of steroid and peptide hormone receptors, metabolic enzymes and EMT-related genes in prostate tumors in relation to the presence of the TMPRSS2/ERG fusion.
Gerashchenko GV; Mevs LV; Chashchina LI; Pikul MV; Gryzodub OP; Stakhovsky EO; Kashuba VI
Exp Oncol; 2018 Jun; 40(2):101-108. PubMed ID: 29949537
[TBL] [Abstract][Full Text] [Related]
11. Study the Expression of CD10 in Prostate Carcinoma and its Correlation with Various Clinicopathological Parameters.
Singh L; Marwah N; Bhutani N; Pawar D; Kapil R; Sen R
Iran J Pathol; 2019; 14(2):135-145. PubMed ID: 31528170
[TBL] [Abstract][Full Text] [Related]
12. Is There a Role for Genetic Information in Risk Assessment and Decision Making in Prostate Cancer?
Nowroozi M; Ayati M; Amini E; Mahdian R; Yousefi B; Arbab A; Jamali Zawarei M; Niroomand H; Ghorbani H; Ghadian A
Nephrourol Mon; 2016 Nov; 8(6):e41505. PubMed ID: 27933279
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic use of ERG in resolving an "atypical glands suspicious for cancer" diagnosis in prostate biopsies beyond that provided by basal cell and α-methylacyl-CoA-racemase markers.
Shah RB; Tadros Y; Brummell B; Zhou M
Hum Pathol; 2013 May; 44(5):786-94. PubMed ID: 23158212
[TBL] [Abstract][Full Text] [Related]
14. Partial atrophy on prostate needle biopsy cores: a morphologic and immunohistochemical study.
Wang W; Sun X; Epstein JI
Am J Surg Pathol; 2008 Jun; 32(6):851-7. PubMed ID: 18408595
[TBL] [Abstract][Full Text] [Related]
15. Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma.
Boran C; Kandirali E; Yilmaz F; Serin E; Akyol M
Urol Oncol; 2011; 29(6):614-23. PubMed ID: 20189848
[TBL] [Abstract][Full Text] [Related]
16. Lack of ERG-antibody in Benign Mimickers of Prostate Cancer.
Bachurska SY; Staykov DG; Ivanov GP; Belovezhdov VT
Folia Med (Plovdiv); 2016 Mar; 58(1):48-53. PubMed ID: 27383878
[TBL] [Abstract][Full Text] [Related]
17. Correlations of PTEN and ERG Immunoexpression in Prostate Carcinoma and Lesions Related to Its Natural History: Clinical Perspectives.
Voulgari O; Goutas D; Pergaris A; Belogiannis K; Thymara E; Kavantzas N; Lazaris AC
Curr Issues Mol Biol; 2023 Mar; 45(4):2767-2780. PubMed ID: 37185705
[No Abstract] [Full Text] [Related]
18. Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy.
Farinola MA; Epstein JI
Hum Pathol; 2004 Oct; 35(10):1272-8. PubMed ID: 15492996
[TBL] [Abstract][Full Text] [Related]
19. The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center.
Nie L; Pan X; Zhang M; Yin X; Gong J; Chen X; Xu M; Zhou Q; Chen N
Prostate; 2019 Jun; 79(8):819-825. PubMed ID: 30900303
[TBL] [Abstract][Full Text] [Related]
20. The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies.
Yaskiv O; Zhang X; Simmerman K; Daly T; He H; Falzarano S; Chen L; Magi-Galluzzi C; Zhou M
Am J Surg Pathol; 2011 Jul; 35(7):1062-8. PubMed ID: 21623182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
